about
Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R.The effect of wool hydrolysates on squamous cell carcinoma cells in vitro. Possible implications for cancer treatment.Structure-activity relationship study of tetrapeptide inhibitors of the Vascular Endothelial Growth Factor A binding to Neuropilin-1.Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders.Opioid Tripeptides Hybridized with trans-1-Cinnamylpiperazine as Proliferation Inhibitors of Pancreatic Cancer Cells in Two- and Three-Dimensional in vitro Models.Conformational latitude - activity relationship of KPPR tetrapeptide analogues toward their ability to inhibit binding of vascular endothelial growth factor 165 to neuropilin-1.Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1.Triazolopeptides Inhibiting the Interaction between Neuropilin-1 and Vascular Endothelial Growth Factor-165.Peptides and peptidoaldehydes as substrates for the Pictet-Spengler reactionDesign, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal CysteineBranched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activityUrea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A165/NRP-1 complexNeuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method
P50
Q30847079-096986F5-CEA1-47D1-8851-3446B629F055Q38599730-501BE44D-E2BE-4ABA-8E34-43DDC4E50A60Q38669500-04AFE053-1F09-44E9-9384-44E0E12171ACQ39100399-1D1144FB-9F60-4A5F-A3E8-160BE0C630B8Q44348324-4B02D419-208D-43C7-9328-ACD13D30A098Q48201168-172CCBC4-E320-4827-9166-F703D12EDD28Q51302575-858C95ED-CB30-4618-BEB5-F61E81368CBCQ64988358-6EEC805C-9FF8-49DA-8E45-C52D07E64D9BQ86861568-B76BCE1A-295E-4229-8BA3-5D2069E10AD0Q89363648-972A2457-1E53-4D6D-BE98-055EC5D5A35DQ90397804-D8327712-E5D6-41E8-B6EA-B48DE39E6D73Q91628313-CB54B766-8828-489D-900F-F67AFFD4521FQ92046610-7C65565A-C4C8-4992-9BA5-E23E35C30114Q92431378-5703C2F2-C397-43C9-88BF-BF3F5466269C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna K Puszko
@ast
Anna K Puszko
@en
Anna K Puszko
@es
Anna K Puszko
@nl
type
label
Anna K Puszko
@ast
Anna K Puszko
@en
Anna K Puszko
@es
Anna K Puszko
@nl
prefLabel
Anna K Puszko
@ast
Anna K Puszko
@en
Anna K Puszko
@es
Anna K Puszko
@nl
P106
P1153
55746925800
P21
P31
P496
0000-0001-7863-6146